Sun Pharma Q3 Results: Cons PAT jumps 16% YoY to Rs 3,369 crore; revenue up 13% by ET Markets | January 31, 2026 4:05 pm | Indian Stocks, Market, News The company’s revenue from operations jumped 13% to Rs 15,520 crore, the company said in a regulatory filing. This translates to a 13% jump from Rs 13,675 crore in the corresponding quarter of the previous financial year.
